DRL announces sale of its antibiotic manufacturing site in Bristol, Tennessee
The 390,000-square-foot facility has been sold to Neopharma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s Laboratories announces that it has regained worldwide rights to DFA-02
DFA-02 is a combination, broad spectrum antibacterial in situ gel which is being investigated for the prophylaxis of SSIs as an…
Lupin and Lilly partner for improved access to diabetes treatment in India
This announcement builds on the Lupin and Lilly India business partnership initiated in 2011 to expand the promotion and…
A Vaidheesh is re-elected President of OPPI
A Vaidheesh, Vice President, South Asia & Managing Director, GlaxoSmithKline Pharmaceuticals has been re-elected as the…
Maruti Suzuki partners with Zydus, sets up modern polyclinic in Becharaji, Gujarat
Facility to provide OPD, X-ray, ultrasound, ECG, pathology and minor operation services at subsidised rates
Multisorb commences manufacturing operations in Hyderabad
New facility brings Multisorb and Filtration Group closer to customers in growing India pharmaceutical market
Alchem launches AlchemLife’s PhytoRelief-CC for cold and cough
The medicine includes natural ingredients that the company claims are significantly effective in curing cough and cold
Culture of 3D Cell Aggregates in Perfusion
Three-dimensional (3D) cell aggregates are of great interest for many applications, including disease modeling, drug toxicity…
Global leaders meet at first-ever UN tuberculosis summit
Governments must act rapidly to expand access to safer, more effective, injection-free treatment regimens
Abbott’s Portico transcatheter aortic valve reduces severe aortic stenosis
Patients who received a Portico aortic heart valve had low rates of stroke, death and valve leak; and improved quality of life